|
NEK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.94839757847876E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.55940000000122E-05 |
| Normal-vs-Stage2 |
3.449800E-02 |
| Normal-vs-Stage3 |
1.6026799999902E-05 |
| Normal-vs-Stage4 |
2.293600E-02 |
| Stage1-vs-Stage2 |
2.429600E-01 |
| Stage1-vs-Stage3 |
2.763200E-04 |
| Stage1-vs-Stage4 |
6.705800E-02 |
| Stage2-vs-Stage3 |
3.473600E-01 |
| Stage2-vs-Stage4 |
2.243200E-01 |
| Stage3-vs-Stage4 |
5.129000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69519998038936E-09 |
| Normal-vs-AfricanAmerican |
1.235450E-04 |
| Normal-vs-Asian |
7.322100E-02 |
| Caucasian-vs-AfricanAmerican |
9.949400E-01 |
| Caucasian-vs-Asian |
8.761600E-01 |
| AfricanAmerican-vs-Asian |
8.506800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.67240016174719E-10 |
| Normal-vs-Female |
1.51838999999931E-05 |
| Male-vs-Female |
1.635630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.416300E-04 |
| Normal-vs-Extreme_Weight |
1.23519999994937E-06 |
| Normal-vs-Obese |
1.67267999999776E-05 |
| Normal-vs-Extreme_Obese |
5.165700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.627000E-01 |
| Normal_Weight-vs-Obese |
7.651000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.130390E-02 |
| Extreme_Weight-vs-Obese |
4.471600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.686200E-02 |
| Obese-vs-Extreme_Obese |
9.583700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.717700E-03 |
| Normal-vs-Age(41-60Yrs) |
6.27510043926804E-10 |
| Normal-vs-Age(61-80Yrs) |
5.93649999999224E-05 |
| Normal-vs-Age(81-100Yrs) |
1.221710E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.131700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.297400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.774070E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.356000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.136000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.805980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.64840000002908E-06 |
| Normal-VS-Type2 PRCC |
3.4190000000045E-06 |
| Normal-VS-KIRP CIMP |
5.411900E-04 |
| Normal-VS-Unclassified PRCC |
2.219400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.882100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.58200000047282E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
4.277400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.840500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.624400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.023000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.85560000000229E-05 |
| Normal-vs-N1 |
1.578420E-04 |
| Normal-vs-N2 |
1.282590E-01 |
| N0-vs-N1 |
1.977550E-03 |
| N0-vs-N2 |
2.294800E-01 |
| N1-vs-N2 |
7.225600E-01 |
|
|
